145 related articles for article (PubMed ID: 20510541)
1. Postoperative chemoradiotherapy for extrahepatic bile duct cancer.
Park JH; Choi EK; Ahn SD; Lee SW; Song SY; Yoon SM; Kim YS; Lee YS; Lee SG; Hwang S; Lee YJ; Park KM; Kim TW; Chang HM; Lee JL; Kim JH
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):696-704. PubMed ID: 20510541
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery.
Park HJ; Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Anticancer Res; 2014 Nov; 34(11):6685-90. PubMed ID: 25368275
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
Deodato F; Clemente G; Mattiucci GC; Macchia G; Costamagna G; Giuliante F; Smaniotto D; Luzi S; Valentini V; Mutignani M; Nuzzo G; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):483-8. PubMed ID: 16242254
[TBL] [Abstract][Full Text] [Related]
4. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.
Kim MW; Kim WH; Wang HJ; Chung JB; Chun M
Hepatogastroenterology; 2001; 48(41):1298-301. PubMed ID: 11677950
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
Milano MT; Chmura SJ; Garofalo MC; Rash C; Roeske JC; Connell PP; Kwon OH; Jani AB; Heimann R
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):445-53. PubMed ID: 15145161
[TBL] [Abstract][Full Text] [Related]
6. Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy.
Gwak HK; Kim WC; Kim HJ; Park JH
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):194-8. PubMed ID: 19910130
[TBL] [Abstract][Full Text] [Related]
7. Impact of adjuvant radiation therapy for microscopic residual tumor after resection of extrahepatic bile duct cancer.
Matsuda T; Fujita H; Harada N; Kunimoto Y; Tanaka T; Kimura T; Kitaoka H; Asano E; Hosono M; Hayashi T; Ogino K
Am J Clin Oncol; 2013 Oct; 36(5):461-5. PubMed ID: 22706178
[TBL] [Abstract][Full Text] [Related]
8. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer.
Kim SW; Noh OK; Kim JH; Chun M; Oh YT; Kang SY; Lee HW; Park RW; Yoon D
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1161-1167. PubMed ID: 28447209
[TBL] [Abstract][Full Text] [Related]
10. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer.
Kim TH; Han SS; Park SJ; Lee WJ; Woo SM; Moon SH; Yoo T; Kim SS; Kim SH; Hong EK; Kim DY; Park JW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e853-9. PubMed ID: 21497455
[TBL] [Abstract][Full Text] [Related]
11. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy with doxifluridine and paclitaxel for extrahepatic bile duct cancer.
Park JY; Park SW; Chung JB; Seong J; Kim KS; Lee WJ; Song SY
Am J Clin Oncol; 2006 Jun; 29(3):240-5. PubMed ID: 16755176
[TBL] [Abstract][Full Text] [Related]
13. [Conformal therapy of locally advanced cholangiocarcinoma of the main bile ducts].
Bouras N; Caudry M; Saric J; Bonnel C; Rullier E; Trouette R; Demeaux H; Maire JP
Cancer Radiother; 2002 Feb; 6(1):22-9. PubMed ID: 11899677
[TBL] [Abstract][Full Text] [Related]
14. [Effecting observation of 3-dimensional conformal radiotherapy combined with chemotherapy for rectal cancer of postoperative local recurrence].
Wu DH; Chen LH
Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):901-3. PubMed ID: 15363248
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer.
Nomura M; Yamakado K; Nomoto Y; Nakatsuka A; Ii N; Shoji K; Takeda K
Int J Oncol; 2002 Feb; 20(2):325-31. PubMed ID: 11788896
[TBL] [Abstract][Full Text] [Related]
16. [Long-term results of 84 surgically treated patients with extrahepatic bile duct carcinoma].
Zheng SS; Qin YS; Liang TB; Huang DS; Zhang M; Wang WL; Shen Y; Wang JH
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):554-6. PubMed ID: 16438856
[TBL] [Abstract][Full Text] [Related]
17. External radiotherapy and extrahepatic bile duct cancer.
Tollenaar RA; van de Velde CJ; Taat CW; Gonzalez Gonzalez D; Leer JW; Hermans J
Eur J Surg; 1991 Oct; 157(10):587-9. PubMed ID: 1687249
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer.
Lee HS; Lee SH; Roh YH; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
Chemotherapy; 2016; 61(3):152-8. PubMed ID: 26788726
[TBL] [Abstract][Full Text] [Related]
19. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of resection and intraoperative radiation for patients with carcinomas of extrahepatic bile duct and ampulla of Vater: prognostic advantage over resection alone?
Nakano K; Chijiiwa K; Toyonaga T; Ueda J; Takamatsu Y; Kimura M; Nakamura K; Yamaguchi K; Tanaka M
Hepatogastroenterology; 2003; 50(52):928-33. PubMed ID: 12845952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
